Trials / Completed
CompletedNCT00592111
A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
Study Hypothesis: Clinical staging without laparotomy/splenectomy is adequate for children and young adults with Hodgkin's disease who receive chemotherapy as a component of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | COPP/ABV | 4 courses of COPP/ABV hybrid |
| DRUG | COPP/ABV | 6 courses of COPP/ABV hybrid |
| DRUG | intensive chemo with concurrent growth factor | 6 cycles (2 courses) of intensive chemotherapy with concurrent growth factor |
Timeline
- Start date
- 1996-03-01
- Primary completion
- 1999-02-01
- Completion
- 2008-01-01
- First posted
- 2008-01-11
- Last updated
- 2015-12-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00592111. Inclusion in this directory is not an endorsement.